TRAINING GRANT IN PHARMACOLOGICAL SCIENCES

描述（由申请人提供）：分子生物学研究生培训计划 斯托尼布鲁克的纽约州立大学 培养博士学生在细胞和分子药理学的广泛领域， 在学术界和工业界的职业生涯。该方案是基于在该部的 纽约州立大学石溪分校医学院的药理学科学，但 一个跨部门的教师，包括44个潜在的导师，其中24个是 从其他大学部门或附近的冷泉港实验室 布鲁克海文国家实验室学生们学习生物化学课程， 细胞生物学和分子遗传学在第一年，药理学和 第二年的选修课。课程包括高级课程 神经药理学、信号转导和结构生物学。教师 已招募成员参加培训方案，以加强这些领域。 培训环境包括一个积极的研讨会系列和许可证 参加研讨会和小型课程。培训还包括 药理学本科专业课程的教学经验。 一年级学生参加三个实验室轮换，以准备他们 在44个实验室中的任何一个进行论文研究 培训计划教师。该计划在其24年的时间里培训了89名学生 历史，包括25名目前的受训人员。出席并圆满完成 少数民族学生在该计划证明了一个成功的努力，招聘 保留少数族裔申请人。

DESCRIPTION (provided by applicant): The Graduate Training Program in Molecular and Cellular Pharmacology at the State University of New York at Stony Brook trains Ph.D. students in the broad area of cell and molecular pharmacology for careers in academia and industry. The Program is based in the Department of Pharmacological Sciences in the School of Medicine at SUNY-Stony Brook, but has an interdepartmental faculty including 44 potential mentors, 24 of which are from other University Departments or the nearby Cold Spring Harbor Laboratory and Brookhaven National Laboratories. Students take courses in biochemistry, cell biology and molecular genetics in the first year, with pharmacology and elective courses in the second year. The curriculum includes advanced courses in Neuropharmacology, Signal Transduction and Structural Biology. Faculty members have been recruited to the Training Program to strengthen these areas. The training environment includes an active seminar series and permits participation in research symposia and minicourses. Training also involves experience teaching in courses offered to undergraduate majors in pharmacology. First year students participate in three laboratory rotations to prepare them to undertake dissertation research in any of the 44 laboratories of the Training Program Faculty. The program has trained 89 students in its 24-year history, including 25 current trainees. The presence and successful completion of minority students in the Program attests to a successful effort to recruit and retain minority applicants.